GHK-Cu (Glycyl-L-Histidyl-L-Lysine : Copper) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. First isolated by Loren Pickart in 1973, GHK-Cu has since been studied for its remarkable ability to reset gene expression toward a regenerative state — earning it a place in serious longevity and dermatology research.
Discovery and Natural Occurrence
GHK was first identified in human albumin fractions and found to stimulate liver cell synthesis. Subsequent research revealed it forms a stable complex with Cu(II) ions, dramatically enhancing its biological activity.
In plasma, GHK-Cu concentrations are approximately 200 ng/mL at age 20, declining to around 80 ng/mL by age 60. This age-related decline has prompted researchers to examine whether exogenous GHK-Cu can compensate for falling endogenous levels — particularly in wound healing and tissue maintenance contexts.
Mechanism: Gene Expression Remodeling
What distinguishes GHK-Cu from most peptides is the breadth of its gene expression effects. Studies using whole-genome microarray analysis have found GHK-Cu modulates over 4,000 human genes — upregulating genes involved in tissue repair, anti-oxidant defense, and neurological function while downregulating genes associated with inflammation, cancer progression, and cell death.
Key pathways affected:
- TGF-β signaling: GHK-Cu modulates transforming growth factor-beta pathways involved in collagen synthesis and wound healing
- SPARC/Osteonectin: Upregulated by GHK-Cu, driving extracellular matrix remodeling
- MMP inhibition: GHK-Cu inhibits matrix metalloproteinases that degrade collagen, while simultaneously stimulating new collagen production
- Antioxidant upregulation: SOD (superoxide dismutase) and catalase expression increases observed in research models
Skin and Wound Healing Research
The most extensively studied application of GHK-Cu is wound healing and skin remodeling. Research findings include:
- Accelerated wound closure: In both in vitro and in vivo models, GHK-Cu has consistently shown faster wound healing versus controls
- Collagen and elastin stimulation: Fibroblast cultures exposed to GHK-Cu produce more type I and type III collagen, as well as elastin and proteoglycans
- Skin thickness: Topical application studies have shown measurable increases in dermal thickness — counteracting the thinning associated with photoaging
- Angiogenesis: GHK-Cu promotes blood vessel growth into healing tissue, improving nutrient delivery to repair zones
Anti-Inflammatory and Antioxidant Activity
Beyond structural tissue effects, GHK-Cu demonstrates significant anti-inflammatory properties. It has been shown to reduce TNF-α and IL-6 production in stimulated macrophage cultures, and to scavenge free radicals directly.
Of particular interest to longevity researchers: GHK-Cu appears to reset the transcriptional profile of aged fibroblasts toward younger patterns. This "rejuvenation" of gene expression — rather than simply stimulating one pathway — is what makes GHK-Cu a uniquely interesting research target.
Neurological Research
More recent work has examined GHK-Cu in neurological contexts. Studies suggest it can upregulate genes involved in nerve regeneration and synaptic plasticity, and may have neuroprotective effects in models of cognitive decline. This is an emerging research area with significant interest from longevity-focused investigators.
Published References
Research Use Only. All content is for informational and educational purposes regarding preclinical research. None of the compounds discussed have been approved by the FDA for human therapeutic use. This information does not constitute medical advice.